# Xeris Announces Updates to Its Board of Directors
Canonical URL: https://biopharmsignal.com/news/XERS/xeris-announces-updates-to-its-board-of-directors-f32772e5
Ticker: XERS
Company: Xeris Pharmaceuticals
Source: Xeris Pharmaceuticals
Published: 2026-06-30 11:00 EST
Original Source URL: https://xerispharma.com/news-releases/news-release-details/xeris-announces-updates-its-board-directors
## Summary

Chief Executive Officer John Shannon named Chair of the Board Marla Persky to transition to Lead Independent Director of the Board Board appoints Nerissa Kreher, M.D., effective July 1, 2026 CHICAGO --(BUSINESS WIRE)--Jun. 30, 2026-- Xeris Biopharma Holdings, Inc.

## Article Body
Chief Executive Officer John Shannon named Chair of the Board Marla Persky to transition to Lead Independent Director of the Board Board appoints Nerissa Kreher, M.D., effective July 1, 2026 CHICAGO --(BUSINESS WIRE)--Jun. 30, 2026-- Xeris Biopharma Holdings, Inc.
## Recent Company News
- 2026-07-02 20:05 EST — [CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)](https://biopharmsignal.com/news/XERS/correcting-and-replacing-xeris-announces-inducement-grants-under-nasdaq-listing--0c3e5deb) — Source: Xeris Pharmaceuticals
- 2026-07-02 20:05 EST — [Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)](https://biopharmsignal.com/news/XERS/xeris-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-713b1411) — Source: Xeris Pharmaceuticals
- 2026-06-30 11:00 EST — [Xeris Announces Updates to Its Board of Directors](https://biopharmsignal.com/news/XERS/xeris-announces-updates-to-its-board-of-directors-f32772e5) — Source: Xeris Pharmaceuticals
- 2026-06-25 13:46 EST — [Xeris Biopharma Announces Notice of Allowance From U.S. Patent and Trademark Office for New Patent Covering KEVEYIS®](https://biopharmsignal.com/news/XERS/xeris-biopharma-announces-notice-of-allowance-from-u-s-patent-and-trademark-office-for-new-patent-covering-keveyisr) — Source: Xeris Pharmaceuticals
- 2026-06-25 13:46 EST — [Xeris Biopharma Announces Private Exchange of Convertible Notes](https://biopharmsignal.com/news/XERS/xeris-biopharma-announces-private-exchange-of-convertible-notes) — Source: Xeris Pharmaceuticals
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)